Nu Skin Enterprises, Inc. (NYSE:NUS) insider Joseph Y. Chang sold 13,497 shares of the firm’s stock in a transaction on Wednesday, November 8th. The shares were sold at an average price of $62.06, for a total value of $837,623.82. Following the transaction, the insider now owns 66,563 shares in the company, valued at $4,130,899.78. The sale was disclosed in a document filed with the SEC, which is available at this link.
Shares of Nu Skin Enterprises, Inc. (NYSE NUS) opened at $62.96 on Thursday. Nu Skin Enterprises, Inc. has a 12-month low of $46.35 and a 12-month high of $65.85. The stock has a market capitalization of $3,319.06, a price-to-earnings ratio of 22.28, a PEG ratio of 2.29 and a beta of 1.57. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.18 and a current ratio of 1.78.
Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Wednesday, November 1st. The company reported $0.76 earnings per share for the quarter, hitting the consensus estimate of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The company had revenue of $563.70 million during the quarter, compared to analyst estimates of $562.70 million. During the same quarter last year, the firm posted $0.98 EPS. The firm’s revenue for the quarter was down 6.7% on a year-over-year basis. sell-side analysts predict that Nu Skin Enterprises, Inc. will post 3.23 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Investors of record on Friday, November 17th will be issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.29%. The ex-dividend date is Thursday, November 16th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 52.75%.
TRADEMARK VIOLATION NOTICE: “Insider Selling: Nu Skin Enterprises, Inc. (NUS) Insider Sells $837,623.82 in Stock” was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2017/11/16/insider-selling-nu-skin-enterprises-inc-nus-insider-sells-837623-82-in-stock.html.
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Nu Skin Enterprises by 0.4% in the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 7,249 shares of the company’s stock worth $456,000 after acquiring an additional 31 shares during the last quarter. US Bancorp DE increased its holdings in Nu Skin Enterprises by 3.3% in the 2nd quarter. US Bancorp DE now owns 2,032 shares of the company’s stock worth $128,000 after acquiring an additional 65 shares during the last quarter. Loudon Investment Management LLC increased its holdings in Nu Skin Enterprises by 1.2% in the 2nd quarter. Loudon Investment Management LLC now owns 8,675 shares of the company’s stock worth $545,000 after acquiring an additional 100 shares during the last quarter. Capstone Asset Management Co. increased its holdings in Nu Skin Enterprises by 2.3% in the 2nd quarter. Capstone Asset Management Co. now owns 4,989 shares of the company’s stock worth $314,000 after acquiring an additional 110 shares during the last quarter. Finally, Retirement Systems of Alabama increased its holdings in Nu Skin Enterprises by 0.4% in the 2nd quarter. Retirement Systems of Alabama now owns 64,033 shares of the company’s stock worth $4,024,000 after acquiring an additional 237 shares during the last quarter. 80.13% of the stock is owned by institutional investors.
NUS has been the topic of several recent analyst reports. BidaskClub cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Tuesday, October 17th. Stifel Nicolaus set a $50.00 price objective on Nu Skin Enterprises and gave the company a “sell” rating in a research note on Thursday, August 3rd. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, TheStreet raised Nu Skin Enterprises from a “c+” rating to a “b” rating in a research report on Wednesday, August 2nd. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and four have issued a buy rating to the company’s stock. Nu Skin Enterprises presently has a consensus rating of “Hold” and a consensus price target of $62.00.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.